Oncology

MedTech News for Mammotome, Geneseeq, BaroPace

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Smith+Nephew’s Hip Arthroplasty System; Mammotome Launched the HydroMARK Plus Breast Biopsy Site Marker; FDA Clearance for Pioneering MARS System; CE Marks for NGS-based Test Kits; BaroPace Updated on Non-Pharmacologic Hypertension and Heart Failure Treatment Trial; Quanta Completed Enrollment in Home Run Study

Smith+Nephew Launched Hip Arthroplasty System in India On August 17, 2023, The London-based orthopedic device maker Smith+Nephew announced the launch of its OR3O dual mobility system for use in primary and revision hip arthroplasty in India. The dual mobility implants have a smaller-diameter femoral head than standard options. It latches into a bigger polyethylene insert, boosting stability, lowering the chance of dislocation, and expanding range. The bearing surface of the OR3O system utilizes Smith+Nephew’s advanced Oxinium DH for its liner and proprietary Oxinium on XLPE for its femoral head and polyethylene inserts which makes it different from othe...

Explore More...

Emerging Drugs In Small Cell Lung Cancer Treatment Market

Small Cell Lung Cancer Treatment Market Propels Due to Extremely Robust Pipeline

Latest Pharma News and Updates for Lilly Amgen Roche Pfizer Civica Nacto

Lilly & Boehringer’s Jardiance; BMS Secures a Neoadjuvant Market for Opdivo; Amgen & NHS Signs a Deal; Roche’s Alzheimer Drug gantenerumab; Pfizer’s RSV Vaccine; Civica’s Insulin Biosimilars; Eli Lilly & Incyte’s JAK inhibitor Olumiant; Natco Pharma Launches Revlimid Generic

GSK’s Covifenz; Idorsia’s Quviviq; GSK’s ZEJULA; EMA Expands its Nod for BMS, Eli Lilly, and Novartis Drugs; Cantex Secures Global Licence to Develop Azeliragon; Biocon Acquires Viatris’ Biosimilar Business

With early-stage data, Chimeric antigen receptor T cell (CART) finding its way towards entering Prostate and Kidney Cancer market

Early but strong clinical data of Arvinas’s ARV-110 in Men with mCRPC that support a potential path to accelerated approval

medtech-news-for-motus-evoendo-orthofix-invitae-polyactiva-ra-medical

Motus GI’s Pure-Vu EVS System; EvoEndo’s Single-Use Unsedated TNE System; Orthofix’s OpusTM BA; Invitae’s CE-IVD Cancer Testing Kits; PolyActiva’s PA5108 Ocular Implant; Ra Medical’s DABRA excimer laser system

pharma-news-for-sandoz-agios-organon-bms-sanofi-bayer-lilly

Sandoz’s Generic Revlimid; Agios’ Pyrukynd; Organon Announces 4Q & Full-year Earnings Report; BMS’ CAR-T Drug Breyanzi; Sanofi & Regeneron’s Dupixent Trial; AZ & Daiichi’s Drug Enhertu; Bayer’s Drug Kerendia; Lilly Releases Mirikizumab Data

Nubeqa (darolutamide) increases overall survival in men with mCSPC/HSPC when added to androgen-deprivation treatment (ADT) with docetaxel: ARASENS phase III study

B7-H3, an emerging immune checkpoint molecule in metastatic CRPC and other cancers

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Oncology

Small Cell Lung Cancer Treatment Market Propels Due to Extremely Robust Pipeline

Lilly & Boehringer’s Jardiance; BMS Secures a Neoadjuvant Market for Opdivo; Amgen & NHS Signs a Deal; Roche’s Alzheimer Drug gantenerumab; Pfizer’s RSV Vaccine; Civica’s Insulin Biosimilars; Eli Lilly & Incyte’s JAK inhibitor Olumiant; Natco Pharma Launches Revlimid Generic

Top Five Liquid Biopsy Companies Impacting Cancer Diagnostics Market from 2020 to 2028

Data readout of potential ADCs: Enhertu gears up for Urothelial Carcinoma Market now

PARP inhibitors in Urothelial carcinoma (UC): Hit or miss?

GSK’s Covifenz; Idorsia’s Quviviq; GSK’s ZEJULA; EMA Expands its Nod for BMS, Eli Lilly, and Novartis Drugs; Cantex Secures Global Licence to Develop Azeliragon; Biocon Acquires Viatris’ Biosimilar Business

Osteosarcoma vs Ewing sarcoma

ASCO GU 2022: Renal Cell Carcinoma Highlights

More Views & Analysis

Seagen/Astellas plans to expand their Antibody Drug Conjugate (ADC), Padcev in additional bladder cancer settings?

With early-stage data, Chimeric antigen receptor T cell (CART) finding its way towards entering Prostate and Kidney Cancer market

Early but strong clinical data of Arvinas’s ARV-110 in Men with mCRPC that support a potential path to accelerated approval

Motus GI’s Pure-Vu EVS System; EvoEndo’s Single-Use Unsedated TNE System; Orthofix’s OpusTM BA; Invitae’s CE-IVD Cancer Testing Kits; PolyActiva’s PA5108 Ocular Implant; Ra Medical’s DABRA excimer laser system

Sandoz’s Generic Revlimid; Agios’ Pyrukynd; Organon Announces 4Q & Full-year Earnings Report; BMS’ CAR-T Drug Breyanzi; Sanofi & Regeneron’s Dupixent Trial; AZ & Daiichi’s Drug Enhertu; Bayer’s Drug Kerendia; Lilly Releases Mirikizumab Data

Nubeqa (darolutamide) increases overall survival in men with mCSPC/HSPC when added to androgen-deprivation treatment (ADT) with docetaxel: ARASENS phase III study

B7-H3, an emerging immune checkpoint molecule in metastatic CRPC and other cancers

PARP inhibitors making inroads towards the first line metastatic Castrate-resistant prostate cancer (CRPC) market soon?

Subscribe to our Updates

Daily

Weekly

Monthly